Clinical Trial Update: Pembrolizumab Followed by Chemotherapy for the Treatment of Patients With Classical Hodgkin Lymphoma [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating pembrolizumab followed by chemotherapy for classical Hodgkin lymphoma is described. The trial is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Classical Hodgkin Lymphoma

Drugs mentioned

• KEYTRUDA (PEMBROLIZUMAB)

Snippet

Sponsor: Northwestern University | Conditions: Classic Hodgkin Lymphoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING